Last reviewed: May 16, 2026

Last updated: May 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Found and Calibrate are two prominent telehealth platforms offering GLP-1 medications for weight management and metabolic health. Both provide remote prescribing and medication delivery, but they differ in pricing structures, clinical monitoring protocols, and personalization depth. Neither platform directly predicts how your body will respond to a specific GLP-1 medication—individual factors including genetics, comorbidities, and prior drug tolerance matter significantly.

Choosing between telehealth providers requires more than cost comparison. Understanding your genetic predispositions in peptide signaling pathways—such as GLP1R and GIPR variants—can provide clinical context for which program model and medication formulation may align with your overall health strategy. PlexusDx emphasizes precision-wellness decision-making through biomarker and genetic insights, supporting a more informed conversation with whichever provider you ultimately select.

Program Structure and Clinical Model Differences

Found emphasizes monthly visits with a registered nurse or physician assistant, focusing on rapid optimization and side-effect management. Calibrate combines medication access with behavioral coaching and longer-term monitoring, positioning itself as a comprehensive weight-loss program. Both models have merit; your choice depends on whether you prefer frequent clinical touchpoints or a structured behavioral framework alongside medication.

Neither program is inherently superior—program fit depends on your baseline health literacy, comfort with self-monitoring, and preference for ongoing behavioral support versus medication-focused optimization. If you have metabolic complexity or prior medication sensitivities, more frequent clinical contact may benefit you. If structured coaching resonates with your learning style, Calibrate's integrated model may be appealing.

Cost, Access, and Insurance Coverage Landscape

Found's pricing typically ranges from $99–$199 monthly (medication plus clinical fees), with variable insurance acceptance depending on your plan and diagnosis. Calibrate's model is generally higher at $250–$300+ monthly, reflecting the integrated coaching and longer appointment duration. Both accept certain commercial plans; cash pricing is significantly cheaper than insurance claims for many patients.

Factor Found Calibrate
Typical Monthly Cost $99–$199 $250–$300+
Insurance Acceptance Variable by plan Variable by plan
Clinical Visit Frequency Monthly (default) Monthly + coaching calls
Medication Type Brand (Ozempic, Wegovy, Mounjaro) or generic semaglutide Brand (Ozempic, Wegovy, Mounjaro) or generic semaglutide
Onboarding Assessment Telehealth intake Expanded metabolic history

Genetic Predispositions and Medication Response Variability

GLP-1 response varies widely between individuals, driven by genetics, gut microbiota, insulin sensitivity, and metabolic baseline. Key genetic variants in GLP1R, GIPR, FTO, and MC4R pathways may correlate with how your body processes and responds to peptide medications. Neither Found nor Calibrate routinely test for these predispositions, meaning both rely on empirical dose escalation and side-effect reporting during treatment.

Understanding your peptide pathway genetics does not predict exact medication response, but it may provide clinical context for why you experience certain side effects or weight-loss trajectories. For example, FTO rs9939609 variants correlate with baseline adiposity and appetite regulation; GIPR rs1800437 relates to glucose-dependent insulinotropic peptide signaling. This information can support a more nuanced conversation with any provider about medication formulation, dosing pace, and realistic expectations.

Safety Considerations and Who Benefits Most from Each Model

Found's frequent monthly visits support rapid identification of adverse effects like nausea, constipation, or pancreatitis symptoms, making it suitable for patients with complex comorbidities or polypharmacy. Calibrate's behavioral coaching can benefit patients who struggle with satiety signaling dysfunction or emotional eating; the structured program may improve long-term adherence and lifestyle integration. Neither model addresses genetic risk factors directly unless you proactively seek testing elsewhere.

Common GLP-1 side effects—nausea, vomiting, constipation, and risk of dehydration—require clinical monitoring regardless of program choice. Patients with personal or family history of thyroid cancer, pancreatitis, or multiple endocrine neoplasia type 2 should disclose these to any provider. Both platforms screen for contraindications, but your genetic profile may inform which medication formulation or titration schedule a provider recommends for safer dosing.

How PlexusDx Supports a More Personalized Approach

PlexusDx offers compounded GLP-1 medications—semaglutide and tirzepatide from licensed 503A pharmacies—at lower price points than many telehealth platforms, typically $149/mo monthly. Compounded options may provide cost-effective access while allowing you to work with a telehealth provider of your choice (Found, Calibrate, or your primary care physician). Pricing alone does not determine clinical fit; understanding your genetic context in peptide pathways may help you prioritize which program features matter most to your health goals.

PlexusDx Precision Peptide Genetic Test ($99 add-on or $298 standalone) reveals predispositions in GLP1R, GIPR, FTO, and MC4R pathways. These variants do not predict exact medication response or guarantee weight loss; instead, they may provide clinical context about your baseline appetite regulation, insulin sensitivity, and metabolic risk profile. This information is most useful when interpreted alongside your healthcare provider's clinical assessment, not as a standalone decision tool.

If you are comparing Found and Calibrate, consider requesting that your chosen provider review your Precision Peptide Genetic Test results as part of your baseline assessment. This may support a more informed conversation about medication formulation choice, expected titration pace, and realistic side-effect management. PlexusDx compounded medications can work within either telehealth ecosystem, giving you flexibility to select the program model that fits your preferences while leveraging genetic insights for personalization.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Microdose Glp1 Protocol starts at $129/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the main difference between Found and Calibrate?

Found emphasizes frequent clinical visits and rapid medication optimization, while Calibrate integrates behavioral coaching and longer-term program structure. Found is typically lower cost; Calibrate offers more comprehensive coaching. Both offer telehealth GLP-1 access with variable insurance coverage.

Can genetics predict which GLP-1 will work best for me?

No single genetic test predicts exact medication response. However, variants in GLP1R, GIPR, FTO, and MC4R pathways may correlate with baseline appetite signaling and metabolic risk. This context should be interpreted by your provider alongside clinical assessment, not as a standalone predictor.

How does PlexusDx fit into the Found vs Calibrate decision?

PlexusDx offers compounded semaglutide and tirzepatide through licensed 503A pharmacies at $149/mo monthly, typically lower than Found or Calibrate. You can use PlexusDx medications while working with either program or your primary provider, giving you flexibility in program choice and cost management.

What safety monitoring should I expect with GLP-1 treatment?

Both Found and Calibrate screen for contraindications and monitor for nausea, vomiting, constipation, dehydration, and rare pancreatitis. Frequent clinical visits (Found) or behavioral check-ins (Calibrate) support early adverse-effect detection.

Does PlexusDx Precision Peptide Genetic Test help me choose between Found or Calibrate?

The test reveals predispositions in peptide pathways that may inform your baseline metabolic profile, but does not predict which program is best for you. Results should be shared with your chosen provider to support personalized treatment planning and realistic expectation-setting around side effects and weight-loss pace.

Related Reading

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves